Registered Nurse in Ellsworth, ME Accepting Medicare

4 Registered Nurse nurses found. Showing 1 - 4

Mrs. Judith Mae Jones, Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 415 Water St, Ellsworth, ME 04605 Phone: 207-667-5357    Fax: 207-667-0174

Ms. Elizabeth Joanne Pouwels, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 52 Christian Ridge Rd, Ellsworth, ME 04605 Phone: 207-610-8025

Brittany Marie Burke, RN Registered Nurse - Women's Health Care, Ambulatory Medicare: Not Enrolled in Medicare Practice Location: 102 Main St Ste A, Ellsworth, ME 04605 Phone: 207-573-0270

Gary Roy Germann, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 128 Bucksport Rd Ste A, Ellsworth, ME 04605 Phone: 207-667-6300

News Archive

Pediatric plastic surgeon reconstructs patient's jaw

Pediatric plastic surgeon Rohit Khosla, MD, had never seen a case like it: the 12-year-old boy's face ballooned with a rare, aggressive bone tumor. Although it was non-cancerous, the tumor was destroying the patient's jaw. Khosla knew he would need an innovative approach to save the boy's ability to chew.

Expert panel report on the state of knowledge of food security in northern Canada

A new expert panel report on food security in Northern Canada, has found that food insecurity among northern Aboriginal peoples requires urgent attention in order to mitigate impacts on health and well-being. Aboriginal Food Security in Northern Canada: An Assessment of the State of Knowledge, released today by the Council of Canadian Academies, addresses the diversity of experience that northern First Nations, Inuit, and M-tis households and communities have with food insecurity.

FerroKin BioSciences initiates international Phase 2 study of FBS0701

FerroKin BioSciences today announced the initiation of an international Phase 2 study of FBS0701, a novel once-daily iron chelator in development for the treatment of transfusional iron overload. The Phase 2 study will assess the safety, tolerability, and pharmacodynamics of FBS0701.

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.

Blood pressure medications can lower stroke, heart attack risk in patients with end-stage renal disease

Two classes of blood pressure medications, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), are associated with a 16% lower risk of strokes, heart attacks and death in patients with end-stage renal disease who are undergoing peritoneal dialysis, a new study in the journal, Nephrology Dialysis Transplantation, reports.

Read more Medical News

› Verified 1 days ago